Rankings
▼
Calendar
NXTC FY 2017 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$35M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$582,000
Operating Income
-$16M
Net Income
-$15M
EPS (Diluted)
$-8.17
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$21M
Stock-Based Comp.
$75,000
Balance Sheet
Total Assets
$19M
Total Liabilities
$44M
Stockholders' Equity
-$24M
Cash & Equivalents
$8M
← Q1 2018
All Quarters